23.03
2.50%
-0.59
Handel nachbörslich:
22.02
-1.01
-4.39%
Schlusskurs vom Vortag:
$23.62
Offen:
$23.49
24-Stunden-Volumen:
123.05K
Relative Volume:
0.86
Marktkapitalisierung:
$842.36M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
-9.22%
1M Leistung:
+10.72%
6M Leistung:
+0.00%
1J Leistung:
+0.00%
Rapport Therapeutics Inc Stock (RAPP) Company Profile
Firmenname
Rapport Therapeutics Inc
Sektor
Branche
Telefon
857-321-8020
Adresse
1325 BOYLSTON STREET, BOSTON
Rapport Therapeutics Inc Aktie (RAPP) Neueste Nachrichten
Rapport Therapeutics to Present at Stifel Healthcare - GlobeNewswire
Rapport Therapeutics to Present at Stifel Healthcare Conference and Jefferies London Healthcare Conference in November - StockTitan
Rapport Therapeutics (NASDAQ:RAPP) Shares Gap Up – Still a Buy? - Defense World
Rapport Therapeutics (NASDAQ:RAPP) Shares Gap UpHere's Why - MarketBeat
SG Americas Securities LLC Makes New Investment in Rapport Therapeutics (NASDAQ:RAPP) - Defense World
(RAPP) Trading Report - Stock Traders Daily
Rapport Therapeutics (NASDAQ:RAPP) Trading Down 4.2%Here's Why - MarketBeat
Rapport Therapeutics (NASDAQ:RAPP) Shares Gap DownShould You Sell? - MarketBeat
Jones Trading Initiates Coverage of Rapport Therapeutics (RAPP) with Buy Recommendation - MSN
Rapport Therapeutics (NASDAQ:RAPP) Trading Down 2.7%Time to Sell? - MarketBeat
This Rapport Therapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday - MSN
When (RAPP) Moves Investors should Listen - Stock Traders Daily
Rapport Therapeutics (NASDAQ:RAPP) Sets New 1-Year HighTime to Buy? - MarketBeat
Millennium Management LLC Makes New $2.72 Million Investment in Rapport Therapeutics (NASDAQ:RAPP) - MarketBeat
Rapport Therapeutics (NASDAQ:RAPP) Short Interest Up 32.4% in September - MarketBeat
Rapport Therapeutics (NASDAQ:RAPP) Stock Price Up 5.3%What's Next? - MarketBeat
75,516 Shares in Rapport Therapeutics (NASDAQ:RAPP) Purchased by The Manufacturers Life Insurance Company - MarketBeat
Two more Mass. biotechs raise $330M in IPOs, to debut on Nasdaq - The Business Journals
(RAPP) On The My Stocks Page - Stock Traders Daily
Rapport Therapeutics (NASDAQ:RAPP) Trading Up 7%Should You Buy? - MarketBeat
Rapport Therapeutics (NASDAQ:RAPP) Shares Down 4.1% - MarketBeat
Logos Global Management LP Makes New Investment in Rapport Therapeutics (NASDAQ:RAPP) - MarketBeat
Perceptive Advisors LLC Acquires New Position in Rapport Therapeutics (NASDAQ:RAPP) - MarketBeat
Rapport Therapeutics (NASDAQ:RAPP) Trading 6.2% Higher - MarketBeat
(RAPP) Technical Data - Stock Traders Daily
ARCH Venture Management LLC Makes New $86.73 Million Investment in Rapport Therapeutics (NASDAQ:RAPP) - Defense World
ARCH Venture Management LLC Invests $86.73 Million in Rapport Therapeutics (NASDAQ:RAPP) - MarketBeat
GC Therapeutics Raises $65M Series A - citybiz
Biogen, Alnylam-partnered Camp4 Therapeutics unveils IPO plans - The Business Journals
Rapport Therapeutics Inc. (RAPP) rating initates by TD Cowen - Knox Daily
GC Therapeutics Raises $65M in Series A Funding - FinSMEs
Rapport Therapeutics (NASDAQ:RAPP) Shares Down 2.4% - MarketBeat
Rapport Therapeutics (NASDAQ:RAPP) Stock Price Up 4.7% - Defense World
Reckitt shares up on report of potential homecare asset sale By Investing.com - Investing.com South Africa
Rhythm Pharmaceuticals initiated with a Buy at H.C. Wainwright - TipRanks
Quest Partners LLC Sells 5,882 Shares of iRobot Co. (NASDAQ:IRBT) - Defense World
Sofinnova Investments Inc. Invests $45.39 Million in Rapport Therapeutics (NASDAQ:RAPP) - MarketBeat
Rapport Therapeutics (NASDAQ:RAPP) Trading 4.7% Higher - MarketBeat
RNAZ’s Financial Health: Exploring TransCode Therapeutics Inc’s Debt-to-Equity Ratio of 1.79 - The InvestChronicle
Trimble and Platform Science pushed hard to get deal done before Vegas meeting - Yahoo Finance
Johnson & Johnson Invests $58.11 Million in Rapport Therapeutics (NASDAQ:RAPP) - MarketBeat
Rapport Therapeutics (NASDAQ:RAPP) Shares Gap Up to $19.00 - MarketBeat
(RAPP) Trading Advice - Stock Traders Daily
TD Asset Management Inc Takes Position in Rapport Therapeutics (NASDAQ:RAPP) - MarketBeat
TD Asset Management Inc Invests $2.36 Million in Rapport Therapeutics (NASDAQ:RAPP) - Defense World
Shares of two Mass. biotech IPOs rise on first day of trading - The Business Journals
Rapport Therapeutics (NASDAQ:RAPP) Stock Price Down 5.5% - MarketBeat
The Potential Rise in the Price of Rapport Therapeutics Inc. (RAPP) following insiders activity - Knox Daily
IPO class of 2024 shows value recovery despite mixed stock performance - BioWorld Online
Rapport Therapeutics (NASDAQ:RAPP) Shares Gap Up to $21.20 - MarketBeat
Rapport Therapeutics to Present at Upcoming Epilepsy Medical Conferences - GlobeNewswire
Finanzdaten der Rapport Therapeutics Inc-Aktie (RAPP)
Es liegen keine Finanzdaten für Rapport Therapeutics Inc (RAPP) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
Rapport Therapeutics Inc-Aktie (RAPP) Insiderhandel
Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
---|---|---|---|---|---|---|---|
HEALY JAMES | Director |
Jun 10 '24 |
Buy |
17.00 |
558,824 |
9,500,008 |
1,863,327 |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Kapitalisierung:
|
Volumen (24h):